Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma Cells

Sean A. Misek(Michigan State University), Richard R. Neubig(Michigan State University)
Molecular Pharmacology
November 3, 2021
Cited by 16


Related Papers